Massimo Cristofanilli, M.D.
Professor of Medicine at Northwestern University Feinberg School of Medicine, Associate Director for Precision Medicine and Translational Research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and Director of Northwestern OncoSET. Dr. Cristofanilli is Board Certified by the American Board of Medical Oncology and the European Society for Medical Oncology. Dr. Cristofanilli received his medical degree in 1986 from the University of La Sapienza in Rome, Italy, where he also completed a fellowship in medical oncology. He completed an internship at the Cabrini Medical Center in New York, as well as his residency in internal medicine. That was followed by a fellowship in medical oncology at University of Texas M.D. Anderson Cancer Center. With more than 25 years of clinical, basic science and educational experience, Dr. Cristofanilli is a widely recognized leader in translational research and treatment of breast cancer. Moreover, he is internationally renowned for the development of novel diagnostic and prognostic markers in primary and metastatic breast cancer. His 2004 study published in New England Journal of Medicine on circulating tumor cells (CTCs)—found to be a predictor of progression-free survival and overall survival in metastatic breast cancer patients—sparked a slew of subsequent preclinical and clinical investigations that continue to further our knowledge and molecular understanding of the metastatic process with the potential to impact the treatment and improve the prognosis of those patients affected by recurrent disease. Among his numerous awards are Fellow of the American College of Physicians (2003), US News & World Report- Best Doctor (2009-present), Philadelphia Magazine Best Doctor (2012), Giovan Giacomo Giordano NIAF (National Italian American Foundation) Lifetime Achievement Award for Ethics and Creativity in Medical Research (2012), and American Cancer Society Scientific Research Award, Southeast Region (2012). Professor Cristofanilli will provide consultation on precision medicine, in particular related to cancer diagnosis and treatment.
Jonathan Sweedler, Ph.D.
James R. Eiszner Family Endowed Chair in Chemistry and Director of the School of Chemical Sciences at the University of Illinois at Urbana-Champaign. He is currently Editor-in-Chief of Analytical Chemistry, an American Chemical Society Journal. Professor Sweedler received his B.S. degree in Chemistry from University of California at Davis in 1983 and his Ph.D. from University of Arizona in 1989. Professor Sweedler is internationally renowned for his work in bioanalytical chemistry, with a focus on metabolomics and peptidomics technologies for assaying nanoliter volume samples. Specific technology areas being developed include capillary electrophoresis separation methods, laser-based detection methods, MS-based sampling techniques, nanoliter volume nuclear magnetic resonance (NMR) spectroscopy and micro/nanofluidic sampling. He also applies these methods to study the roles that peptide hormones, neurotransmitters and neuromodulatory agents play in behavior, learning and memory. Among his numerous awards are National Science Foundation (NSF) Young Investigator Award (1992), American Association for the Advancement of Science (AAAS) Fellow (2001), Pittsburgh Analytical Chemistry Award, Society for Analytical Chemists of Pittsburgh (SACP) (2007), Ralph N. Adams Award, The Pittsburgh Conference (2012), and the Analytical Chemistry Award, the American Chemical Society (2014). Professor Sweedler will provide consultation on analytical chemistry, neuroscience, and single cell analysis.
Peidong Yang, Ph.D.
S.K. and Angela Chan Distinguished Professor of Energy, Professor of Chemistry, Director of California Research Alliance by BASF, and Co-director of Kavli Energy Nanoscience Institute, at the University of California, Berkeley. He is also a Senior Faculty Scientist at Lawrence Berkeley National Laboratory. He is an associate editor of the Journal of the American Chemistry Society, an American Chemical Society Journal. He was a founding member of the scientific advisory board at Nanosys Inc., and the co-founder of Alphabet Energy Inc. Dr. Yang received his B.S. degree in Chemistry from USTC in 1993 and his Ph.D. in Chemistry from Harvard University in 1997. Professor Yang is internationally renowned for his work in nanostructure synthesis and characterization, having co-authored over 250 scientific articles and given over 270 invited/plenary talks. In 2011, Professor Yang was ranked as the top materials scientist and among the top 10 chemists of the decade, 2000-2010, and as the 2014 Citation Laureate in Physics by Thomson Reuters, in order of citation impact. Among his numerous awards are NSF Career Award (2001), MIT Technology Review TR100 (2003), NSF Alan T. Waterman Award (2007), Scientific American 50 Award (2008), Elected Member of American Academy of Arts and Science (2012), and Elected Member of National Academy of Sciences (2016). Professor Yang will provide consultation on nanoscience and nanotechnology.